1. bookVolumen 65 (2015): Edición 2 (June 2015)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Rational application of fructose-1,6-diphosphate: From the perspective of pharmacokinetics

Publicado en línea: 23 May 2015
Volumen & Edición: Volumen 65 (2015) - Edición 2 (June 2015)
Páginas: 147 - 157
Aceptado: 22 Dec 2014
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. J. E. Cohen, P. Atluri, M. D. Taylor, T. J. Grand, G. P. Liao, C. M. Panlilio, E. E. Suarez, S. E. Zentko, V. M. Hsu, M. F. Berry, M. J. Smith, T. J. Gardner, H. L. Sweeney and Y. J. Woo, Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction, Heart Lung Circ. 15 (2006) 119-123; DOI: 10.1016/j.hlc.2005.12.004.10.1016/j.hlc.2005.12.004Search in Google Scholar

2. L. Galzigna, V. Rizzoli, M. Bianchi, M. P. Rigobello and R. Scuri, Some effects of fructose-1,6-diphosphate on rat myocardial tissue related to a membrane-stabilizing action, Cell Biochem. Funct. 7 (1989) 91-96; DOI: 10.1002/cbf.290070203.10.1002/cbf.290070203Search in Google Scholar

3. B. Tavazzi, L. Cerroni, D. D. Pierro, G. Lazzarino, M. Nuutinen, J. W. Starnes and B. Giardina, Oxygen radical injury and loss of high-energy compounds in anoxic and reperfused rat heart: prevention by exogenous fructose-1,6-bisphosphate, Free Radic. Res. 10 (1990) 167-176; DOI: 10.3109/10715769009149885.10.3109/10715769009149885Search in Google Scholar

4. A. K. Markov, Hemodynamics and metabolic effects of fructose 1,6-diphosphate in ischemia and shock-experimental and clinical observations, Ann. Emerg. Med. 15 (1986) 1470-1477; DOI: 10.1016/ S0196-0644(86)80946-5.10.1016/S0196-0644(86)80946-5Search in Google Scholar

5. X. T. Wu, J. S. Li, X. F. Zhao, N. Li, Y. K. Ma, W. Zhuang, Y. Zhou and G. Yang, Effects of n-3 fatty acid, fructose-1,6-diphosphate and glutamine on mucosal cell proliferation and apoptosis of small bowel graft after transplantation in rats, World J. Gastroenterol. 9 (2003) 1323-1326.10.3748/wjg.v9.i6.1323Search in Google Scholar

6. T. J. Wheeler, J. M. McCurdy and S. Chien, Permeability of fructose-1,6-bisphosphate in liposomes and cardiac myocytes, Mol. Cell Biochem. 259 (2004) 105-114; DOI: 10.1023/B:MCBI.0000021356.89867.0d.10.1023/B:MCBI.0000021356.89867.0dSearch in Google Scholar

7. T. Kaakinen, A. Naukkarinen, H. Tuominen, P. Romsi, M. Nuutinen, F. Biancari and T. Juvonen, Neuronal ultrastructure is preserved by fructose-1,6-bisphosphate after hypothermic circulatory arrest in pigs, J. Thorac. Cardiov. Sur. 130 (2005) 1475-1476; DOI: 10.1016/j.jtcvs.2005.07.037.10.1016/j.jtcvs.2005.07.037Search in Google Scholar

8. R. Didlake, K. A. Kirchner, J. Lewin, J. D. Bower and A. K. Markov, Attenuation of ischemic renal injury with fructose 1,6-diphosphate, J. Surg. Res. 47 (1989) 220-226; DOI: 10.1016/0022-4804(89)90111-X.10.1016/0022-4804(89)90111-XSearch in Google Scholar

9. N. Antunes, C. A. Martinusso, C. M. Takiya, A. J. Silva, J. F. Ornellas, P. R. Elias, M. Leite, Jr. and L. R. Cardoso, Fructose-1,6-diphosphate as a protective agent for experimental ischemic acute renal failure, Kidney Int. 69 (2006) 68-72; DOI: 10.1038/sj.ki.5000013.10.1038/sj.ki.500001316374425Search in Google Scholar

10. K. Xu and J. L. Stringer, Pharmacokinetics of fructose-1, 6-diphosphate after intraperitoneal and oral administration to adult rats, Pharmacol. Res. 57 (2008) 234-238; DOI 10.1016/j.phrs.2008.01.008.10.1016/j.phrs.2008.01.008271875418325780Search in Google Scholar

11. S. Drabant, I. Klebovich, B. Gachalyi, G. Renczes and C. Farsang, Role of food interaction pharmacokinetic studies in drug development. Food interaction studies of theophylline and nifedipine retard and buspirone tablets, Acta Pharm. Hung. 68 (1998) 294-306.Search in Google Scholar

12. C. S. Won, N. H. Oberlies and M. F. Paine, Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport, Pharmacol. Ther. 136 (2012) 186-201. DOI: 10.1016/j. pharmthera.2012.08.001.Search in Google Scholar

13. L. Yunxia, L. Hongye, X. H. Jiang and C. Peng, Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells, Eur. J. Drug Metab. Ph. 36 (2011) 41-47; DOI: 10.1007/s13318-011-0026-0.10.1007/s13318-011-0026-0Search in Google Scholar

14. P. Artursson and J. Karlsson, Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells, Biochem. Bioph. Res. Co. 175 (1991) 880-885; DOI: 10.1016/0006-291X(91)91647-U.10.1016/0006-291X(91)91647-USearch in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo